Suppr超能文献

抗原呈递细胞上的一种主要共刺激分子,CTLA4配体A,与B7不同。

A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.

作者信息

Wu Y, Guo Y, Liu Y

机构信息

Michael Heidelberger Division of Immunology, Department of Pathology, New York University Medical Center, New York 10016.

出版信息

J Exp Med. 1993 Nov 1;178(5):1789-93. doi: 10.1084/jem.178.5.1789.

Abstract

CTLA4 ligands are important costimulatory molecules because soluble CTLA4Ig blocks the induction of T cell responses and induces T cell tolerance. As CTLA4 immunoglobulin (CTLA4Ig) binds B7 when the latter is expressed on fibroblasts, it was widely assumed that CTLA4Ig blocks T cell costimulation by blocking the function of B7. Here we show that the major costimulatory ligand bound by CTLA4Ig (which we term CTLA4 ligand A) on antigen-presenting cells are not encoded by the B7 gene. CTLA4 ligand A also differs from B7 in cellular distribution and in the respective levels of expression. Both B7 and CTLA4 ligand A are critically involved in T cell costimulation.

摘要

CTLA4配体是重要的共刺激分子,因为可溶性CTLA4Ig可阻断T细胞应答的诱导并诱导T细胞耐受。由于CTLA4免疫球蛋白(CTLA4Ig)在成纤维细胞上表达时可与B7结合,人们普遍认为CTLA4Ig通过阻断B7的功能来阻断T细胞共刺激。在此我们表明,抗原呈递细胞上与CTLA4Ig结合的主要共刺激配体(我们称之为CTLA4配体A)并非由B7基因编码。CTLA4配体A在细胞分布和各自的表达水平上也与B7不同。B7和CTLA4配体A都在T细胞共刺激中起关键作用。

相似文献

1
A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.
J Exp Med. 1993 Nov 1;178(5):1789-93. doi: 10.1084/jem.178.5.1789.
2
Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Transplantation. 1996 Oct 15;62(7):1011-8. doi: 10.1097/00007890-199610150-00021.
3
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
J Exp Med. 1992 Dec 1;176(6):1595-604. doi: 10.1084/jem.176.6.1595.
5
Expression and functional significance of an additional ligand for CTLA-4.
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11054-8. doi: 10.1073/pnas.90.23.11054.
7
Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor.
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11182-6. doi: 10.1073/pnas.90.23.11182.
9
CTLA-4 is a second receptor for the B cell activation antigen B7.
J Exp Med. 1991 Sep 1;174(3):561-9. doi: 10.1084/jem.174.3.561.
10
Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.
Science. 1993 Nov 5;262(5135):907-9. doi: 10.1126/science.7694362.

引用本文的文献

1
pH-dependent dissociation from CTLA-4 in early endosomes improves both safety and antitumor activity of anti-CTLA-4 antibodies.
Proc Natl Acad Sci U S A. 2025 Feb 25;122(8):e2422731122. doi: 10.1073/pnas.2422731122. Epub 2025 Feb 18.
2
Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancer.
BJC Rep. 2024;2. doi: 10.1038/s44276-023-00035-5. Epub 2024 Jan 23.
3
Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4- and PD-1-targeted immunotherapy.
Sci Transl Med. 2023 Mar;15(685):eabm5663. doi: 10.1126/scitranslmed.abm5663. Epub 2023 Mar 1.
4
Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy.
Trends Pharmacol Sci. 2020 Jan;41(1):4-12. doi: 10.1016/j.tips.2019.11.003. Epub 2019 Dec 10.
5
Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy.
Cell Res. 2019 Aug;29(8):609-627. doi: 10.1038/s41422-019-0184-1. Epub 2019 Jul 2.
6
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy.
Cell Res. 2018 Apr;28(4):416-432. doi: 10.1038/s41422-018-0011-0. Epub 2018 Feb 22.
7
Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis.
Sci Transl Med. 2017 Feb 1;9(375). doi: 10.1126/scitranslmed.aah3438.
8
B7 blockade alters the balance between regulatory T cells and tumor-reactive T cells for immunotherapy of cancer.
Clin Cancer Res. 2009 Feb 1;15(3):960-70. doi: 10.1158/1078-0432.CCR-08-1611.
9
Expression of costimulatory molecules in the bovine corpus luteum.
Reprod Biol Endocrinol. 2007 Jan 31;5:5. doi: 10.1186/1477-7827-5-5.

本文引用的文献

5
Identification of a monoclonal antibody specific for a murine T3 polypeptide.
Proc Natl Acad Sci U S A. 1987 Mar;84(5):1374-8. doi: 10.1073/pnas.84.5.1374.
7
T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
Proc Natl Acad Sci U S A. 1990 Jul;87(13):5031-5. doi: 10.1073/pnas.87.13.5031.
8
The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
J Exp Med. 1991 Mar 1;173(3):759-62. doi: 10.1084/jem.173.3.759.
10
Microbial induction of co-stimulatory activity for CD4 T-cell growth.
Int Immunol. 1991 Apr;3(4):323-32. doi: 10.1093/intimm/3.4.323.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验